Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-06-09 | 7,169 | $14.50 | $103.95kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-05-23 | 2,146 | $11.31 | $24.27kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-05-23 | 1,926 | $11.31 | $21.78kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-05-22 | 2,317 | $11.88 | $27.52kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-05-22 | 2,689 | $11.88 | $31.93kSell |
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-05-22 | 9,999 | $11.88 | $118.75kSell |
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-05-19 | 3,808 | $11.84 | $45.10kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-05-19 | 2,600 | $11.84 | $30.79kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-05-19 | 2,776 | $11.84 | $32.88kSell |
Venrock Healthcare Capital Partners III LP | 10% Owner | 2025-04-09 | 25,000 | $9.42 | $235.50kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vivo Ventures VI LLC | 16.91% | 8,409,126 | $134.46M | Insider |
Vr Adviser LLC | 13.48% | 6,703,985 | $107.20M | Institution |
Venrock Healthcare Capital Partners III LP | 10.67% | 5,303,985 | $84.81M | Insider |
Tang Capital Management LLC | 9.94% | 4,941,798 | $79.02M | Institution |
Suvretta Capital Management LLC | 9.88% | 4,913,012 | $78.56M | Institution |
Frazier Life Sciences Management LP | 9.83% | 4,887,867 | $78.16M | Institution |
Vestal Point Capital LP | 9.56% | 4,751,292 | $75.97M | Institution |
Interwest Management Partners IX LLC | 9.29% | 4,619,196 | $73.86M | Insider |
Guy P. Nohra | 8.74% | 4,343,550 | $69.45M | Insider |
Acmp IV LLC | 8.74% | 4,343,550 | $69.45M | Insider |